Charles River Laboratories International Inc. (NYSE: CRL) is 1.28% higher on its value in year-to-date trading and has touched a low of $161.65 and a high of $275.00 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CRL stock was last observed hovering at around $240.13 in the last trading session, with the day’s loss setting it -0.7%.
Currently trading at $239.43, the stock is -3.69% and -5.31% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.71 million and changing -0.29% at the moment leaves the stock 10.78% off its SMA200. CRL registered 17.47% gain for a year compared to 6-month gain of 32.10%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -9.86% loss in the last 1 month and extending the period to 3 months gives it a 12.35%, and is 4.06% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.11% over the week and 2.55% over the month.
Charles River Laboratories International Inc. (CRL) has around 21800 employees, a market worth around $12.29B and $4.13B in sales. Current P/E ratio is 26.00 and Fwd P/E is 19.24. Profit margin for the company is 11.49%. Distance from 52-week low is 48.12% and -12.93% from its 52-week high. The company has generated returns on investments over the last 12 months (7.12%).
The EPS is expected to grow by 3.35% this year
The shares outstanding are 51.34M, and float is at 50.31M with Short Float at 3.15%.
Charles River Laboratories International Inc. (CRL) Insider Activity
The most recent transaction is an insider sale by Knell Michael Gunnar, the company’s CSVP&Chief Accounting Officer. SEC filings show that Knell Michael Gunnar sold 808 shares of the company’s common stock on Mar 08 ’24 at a price of $267.52 per share for a total of $0.22 million. Following the sale, the insider now owns 7024.0 shares.
Charles River Laboratories International Inc. disclosed in a document filed with the SEC on Mar 04 ’24 that Knell Michael Gunnar (CSVP&Chief Accounting Officer) sold a total of 2,750 shares of the company’s common stock. The trade occurred on Mar 04 ’24 and was made at $261.05 per share for $0.72 million. Following the transaction, the insider now directly holds 7832.0 shares of the CRL stock.
Still, SEC filings show that on Feb 29 ’24, Creamer Victoria L (EVP & Chief People Officer) disposed off 5,000 shares at an average price of $253.70 for $1.27 million. The insider now directly holds 13,550 shares of Charles River Laboratories International Inc. (CRL).
